Olena Mandrik (O Mandrik)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

BJU international

PloS one

PharmacoEconomics

Clinical journal of the American Society of Nephrology : CJASN

University of Sheffield

Erasmus University Rotterdam (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Sheffield Oct 15 2018

United Kingdom

Research Fellow :: ScHARR

International Agency for Research on Cancer Sep 01 2016 - Sep 01 2018

France

post-doctoral fellow

Erasmus University Rotterdam May 01 2016 - May 01 2018

Netherlands

researcher :: SHPM

Education History

Erasmus University Rotterdam Nov 05 2011 - Sep 18 2015

Netherlands

PHD :: SHPM

Publications

James W F Catto, Olena Mandrik, Lewis A Quayle, Syed A Hussain, John S McGrath, Joanne Cresswell, Alison J Birtle, Rob J Jones, Paramananthan Mariappan, Lydia E Makaroff, Allen Knight, A Hugh Mostafid, Jim Chilcott, Peter Sasieni, Marcus Cumberbatch
Diagnosis, treatment and survival from bladder, upper urinary tract and urethral cancers: Real world findings from NHS England between 2013 and 2019. BJU international (2023)
James W F Catto, Olena Mandrik, Lewis A Quayle, Syed A Hussain, John S McGrath, Joanne Cresswell, Alison J Birtle, Rob J Jones, Paramananthan Mariappan, Lydia E Makaroff, Allen Knight, A Hugh Mostafid, Jim Chilcott, Peter Sasieni, Marcus Cumberbatch
Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real-world findings from NHS England between 2013 and 2019. BJU international (2023)
Olena Mandrik, Anne I Hahn, James W F Catto, Ann G Zauber, Marcus Cumberbatch, James Chilcott
Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder Cancer Screening and Diagnosis: A Systematic Review. PharmacoEconomics (2023)
Olena Mandrik, James Fotheringham, Shijie Ren, Jeffrey A Tice, Richard H Chapman, Matthew D Stevenson, Steven D Pearson, Serina Herron-Smith, Foluso Agboola, Praveen Thokala
The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States. Clinical journal of the American Society of Nephrology : CJASN 17 (3) (2022)
Olena Mandrik, Chloe Thomas, Sophie Whyte, James Chilcott
Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and Solutions. PharmacoEconomics 40 (4) (2022)
Olena Mandrik, E Tolma, N Zielonke, F Meheus, C Ordóñez-Reyes, J L Hans Severens, R Murillo
Systematic reviews as a "lens of evidence": Determinants of participation in breast cancer screening. Journal of medical screening 28 (2) (2020)
Olena Mandrik, Obinna Ikechukwu Ekwunife, Filip Meheus, Johan L Hans Severens, Stefan Lhachimi, Carin A Uyl-de Groot, Raul Murillo
Systematic reviews as a "lens of evidence": Determinants of cost-effectiveness of breast cancer screening. Cancer medicine 8 (18) (2019)
Olena Mandrik, Nadine Zielonke, Filip Meheus, J L Hans Severens, Neela Guha, Rolando Herrero Acosta, Raul Murillo
Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screening. International journal of cancer 145 (4) (2019)
Lin Li, J L Hans Severens, Olena Mandrik
Disutility associated with cancer screening programs: A systematic review. PloS one 14 (7) (2019)
Olena Mandrik, Alesya Yaumenenka, Rolando Herrero, Marcel F Jonker
Population preferences for breast cancer screening policies: Discrete choice experiment in Belarus. PloS one 14 (11) (2019)

Olena Mandrik.css-eqlu8i{font-size:small;padding-left:4px;} (O Mandrik)

Publication Activity (10 Years)

Top Topics

Top Venues

Olena Mandrik (O Mandrik)